The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Copaxone 40 mg/ml solution for injection in pre-filled syringe

PCO Manufacturing Ltd.PPA0465/432/002

Main Information

Trade NameCopaxone 40 mg/ml solution for injection in pre-filled syringe
Active SubstancesGlatiramer acetate
Dosage FormSolution for injection in pre-filled syringe
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/432/002

Group Information

ATC CodeL03AX Other immunostimulants
L03AX13 glatiramer acetate


License statusAuthorised
Licence Issued15/07/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back